September 2024 is National Ovarian Cancer Awareness Month. Early detection is crucial for better clinical outcomes in ovarian cancer, but symptoms are often absent. In the US, almost 20,000 new cases of ovarian cancer and over 14,000 deaths occur annually. Black women have the lowest survival rates, with a 41% 5-year survival rate compared to 48% for white women. Disparities in access worsen outcomes for black women with ovarian cancer, as they are less likely to receive recommended treatments, possibly due to socioeconomic factors and structural racism. Understanding and addressing these disparities is crucial to improving outcomes for black women with ovarian cancer. It is important for black women to advocate for themselves, seek care from reputable cancer centers, find culturally competent healthcare providers, consider participating in clinical trials, and connect with support networks. This educational resource was prepared with support from Merck.